1Y Close · As of Aug 26, 2026
Orum Therapeutics operates in the Pharmaceuticals sector.
Legal name: Orum Therapeutics, Inc.
In fiscal year 2025, Orum Therapeutics (475830) reported revenue of 24 million KRW, down 99.9% from 20.9 billion KRW a year earlier.
Operating profit was -51.8 billion KRW and net income was -42.0 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 1.48 trillion KRW, with a P/B of 11.32.
These figures can be verified in the DART filing (receipt no. 20260319001320).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 24M | -51.8B | -42.0B |
| 2024 | 20.9B | -8.3B | -5.7B |
| 2023 | 135.4B | 95.6B | 68.2B |
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-18 | 전환주식의전환가액조정 (전환우선주) |
| 2026-08-14 | 전환주식의전환가액조정 (전환우선주) |
| 2026-08-14 | Semi-Annual Report (2026.06) |